沃华医药：董事、董事会秘书张戈拟减持不超过约251万股

Group 1 - The core point of the article is that Wohuah Pharmaceutical announced a plan for a significant share reduction by a board member, which may impact investor sentiment and stock performance [1] - Zhang Ge, a board member and secretary, plans to reduce his holdings by up to approximately 2.51 million shares, representing about 1.74% of the company's total share capital [1] - As of the report, Wohuah Pharmaceutical has a market capitalization of 4.2 billion yuan [1] Group 2 - For the first half of 2025, Wohuah Pharmaceutical's revenue composition is entirely from the pharmaceutical industry, with a 100% contribution [1]